MARKET COMPOSITE
Market TodayThemes and Stocks SummaryThematic Stock SearchFAQAbout
Home/
VCEL - Vericel Corp3:51:34 PM 4/25/2024
Price
$44.85
-1.26 (-2.72%)
Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures, and distributes cellular therapies for sports medicine and severe burn care markets in the United States. It markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of patients with deep-dermal or full-thickness burns. The company also develops ixmyelocel-T, a patient-specific multicellular therapy that has completed Phase IIb clinical trial for the treatment of advanced heart failure due to dilated cardiomyopathy. In addition, its preapproval stage product includes, NexoBrid, a registration-stage biological orphan product for debridement of severe thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was founded in 1989 and is headquartered in Cambridge, Massachusetts.
Financials
Quarterly financials
(USD)Dec 2023Q/Q
Revenue65MM+43%
Gross Profit48.5MM+58%
Cost Of Revenue16.5MM+10%
Operating Income12.7MM-352%
Operating Expenses35.8MM+0%
Net Income13MM-455%
R&D4.9MM-14%
G&A30.9MM+3%
Interest Expense156K+4%
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Related
Topics
Medical Specialties-0.10%
Peers
NEOG0.50%
RPRX0.60%
leak data
Stock news

Load more